摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-benzoyl-2-methyl-2,3-dihydro-1H-quinolin-4-one | 681828-20-6

中文名称
——
中文别名
——
英文名称
1-benzoyl-2-methyl-2,3-dihydro-1H-quinolin-4-one
英文别名
1-Benzoyl-2-methyl-2,3-dihydroquinolin-4(1H)-one;1-benzoyl-2-methyl-2,3-dihydroquinolin-4-one
1-benzoyl-2-methyl-2,3-dihydro-1H-quinolin-4-one化学式
CAS
681828-20-6
化学式
C17H15NO2
mdl
——
分子量
265.312
InChiKey
QEFXWQPMGCAJAH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    37.4
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:6cc52357f90f4f337193f915a634a28b
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-benzoyl-2-methyl-2,3-dihydro-1H-quinolin-4-one四氯化钛 三乙酰氧基硼氢化钠三乙胺 作用下, 以 1,1-二氯乙烷溶剂黄146甲苯 为溶剂, 反应 1.0h, 生成 (2-methyl-4-prop-2-ynylamino-3,4-dihydro-2H-quinolin-1-yl)-phenyl-methanone
    参考文献:
    名称:
    Quinoline derivatives as CRTH2 antagonists
    摘要:
    该发明涉及公式(I)中R1、R2、R3、R4、R5、R6、R7和R8的化合物,其用作药物、含有它们的药物组合物以及它们的制备方法。
    公开号:
    EP1435356A1
  • 作为产物:
    描述:
    2,3-二氢-2-甲基-4(1h)-喹啉酮苯甲酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 以90%的产率得到1-benzoyl-2-methyl-2,3-dihydro-1H-quinolin-4-one
    参考文献:
    名称:
    Tetrahydroquinoline derivatives as CRTH2 antagonists
    摘要:
    A series of tetrahydroquinoline-derived inhibitors of the CRTH2 receptor was discovered by a high throughput screen. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent and orally bioavailable CRTH2 antagonists. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.10.094
点击查看最新优质反应信息

文献信息

  • Quinoline Derivatives as CRTH2 Antagonists
    申请人:Ali Awad M. Mohamed
    公开号:US20070197587A1
    公开(公告)日:2007-08-23
    The invention relates to compounds of formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
    该发明涉及式(I)的化合物,其中R1、R2、R3、R4、R5、R6、R7和R8如描述中所定义,它们作为药物的用途、含有它们的制药组合物以及它们的制备方法。
  • TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS
    申请人:Warner-Lambert Company LLC
    公开号:EP1556356A1
    公开(公告)日:2005-07-27
  • US7220760B2
    申请人:——
    公开号:US7220760B2
    公开(公告)日:2007-05-22
  • [EN] TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS<br/>[FR] DERIVES DE TETRAHYDROQUINOLINE ANTAGONISTES DE CRTH2
    申请人:WARNER LAMBERT CO
    公开号:WO2004035543A1
    公开(公告)日:2004-04-29
    The invention relates to compounds of formula (I) wherein Rl, R2, R3, R4, R5, R6, R7 and R8 are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
  • Tetrahydroquinoline derivatives as CRTH2 antagonists
    作者:Jiwen Liu、Yingcai Wang、Ying Sun、Derek Marshall、Shichang Miao、George Tonn、Penny Anders、Joel Tocker、H. Lucy Tang、Julio Medina
    DOI:10.1016/j.bmcl.2009.10.094
    日期:2009.12
    A series of tetrahydroquinoline-derived inhibitors of the CRTH2 receptor was discovered by a high throughput screen. Optimization of these compounds for potency and pharmacokinetic properties led to the discovery of potent and orally bioavailable CRTH2 antagonists. (C) 2009 Elsevier Ltd. All rights reserved.
查看更多